Personalized Medicine: TissueGnostics majorly contributes to a dossier

Medianet dossier

On October 5th 2018 the Austrian Medianet magazine published a health economy dossier on Personalized Medicine.
Medianet has the largest reach of all Austrian trade journals and is mainly read by managers, decision makers and stakeholders in the Austrian economy.

Medianet reach

TissueGnostics globally contributes to research which boosts Personalized Medicine through cooperation projects and enabling research done by its clients. Therefore the company was invited to organize a round table on the subject with Austrian experts and also to provide further insights from its cooperation partners.

The round table was held at TissueGnostics premises with TGs CEO, Rupert Ecker, taking part as an expert.

round table

The dossier will be included in the medianet print journal, with a circulation of 14.000 and as an e-paper with a circulation of 42.000 .

A download of a pdf version of the dossier is available here.

Die deutsche pdf-Version können Sie hier herunterladen.

HAPPY BIRTHDAY TissueGnostics!

BDay cake anim

18th of April 2003.

 15 years ago on this day, TissueGnostics GmbH was entered in the company register of the Vienna Business Court.

Continue Reading

TissueGnostics Asia Pacific Ltd is open for business

TissueGnostics expands its operations in the Far East with the opening of its Asia-Pacific branch, with offices in Hong Kong, China.

Continue Reading

TissueGnostics feiert 13. Geburtstag und gewinnt internationalen Preis für Bildanalyse


Der Wiener Medizintechnik-Spezialist TissueGnostics GmbH feiert heuer sein 13-jähriges Firmenjubiläum.

Das Unternehmen ist mit seinen Produkten in mehr als 30 Ländern vertreten und wurde kürzlich mit einem internationalen Preis für die beste Bildanalyse in der digitalen Pathologie ausgezeichnet. Diese Erfolge feierte TissueGnostics mit einem Symposium in den Tiroler Alpen.

Continue Reading

zh cn
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok